These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 22932705

  • 1. Intermittent levosimendan infusions in advanced heart failure: favourable effects on left ventricular function, neurohormonal balance, and one-year survival.
    Malfatto G, Della Rosa F, Villani A, Rella V, Branzi G, Facchini M, Parati G.
    J Cardiovasc Pharmacol; 2012 Nov; 60(5):450-5. PubMed ID: 22932705
    [Abstract] [Full Text] [Related]

  • 2. Acute effects of levosimendan on mitral regurgitation and diastolic function in patients with advanced chronic heart failure.
    Branzi G, Malfatto G, Villani A, Ciambellotti F, Revera M, Giglio A, Rosa FD, Facchini M, Parati G.
    J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):662-8. PubMed ID: 20613551
    [Abstract] [Full Text] [Related]

  • 3. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
    Adamopoulos S, Parissis JT, Iliodromitis EK, Paraskevaidis I, Tsiapras D, Farmakis D, Karatzas D, Gheorghiade M, Filippatos GS, Kremastinos DT.
    Am J Cardiol; 2006 Jul 01; 98(1):102-6. PubMed ID: 16784930
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of noninvasive hemodynamic evaluation of the acute effect of levosimendan in advanced heart failure.
    Malfatto G, Della Rosa F, Rella V, Villani A, Branzi G, Blengino S, Giglio A, Facchini M, Parati G.
    J Cardiovasc Med (Hagerstown); 2014 Apr 01; 15(4):322-30. PubMed ID: 24699010
    [Abstract] [Full Text] [Related]

  • 5. Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation.
    Zemljic G, Bunc M, Yazdanbakhsh AP, Vrtovec B.
    J Card Fail; 2007 Aug 01; 13(6):417-21. PubMed ID: 17675054
    [Abstract] [Full Text] [Related]

  • 6. Repeated infusions of levosimendan: well tolerated and improves functional capacity in decompensated heart failure - a single-centre experience.
    Parle NM, Thomas MD, Dembo L, Best M, Driscoll GO.
    Heart Lung Circ; 2008 Jun 01; 17(3):206-10. PubMed ID: 18242130
    [Abstract] [Full Text] [Related]

  • 7. Effect of levosimendan on estimated glomerular filtration rate in hospitalized patients with decompensated heart failure and renal dysfunction.
    Hou ZQ, Sun ZX, Su CY, Tan H, Zhong X, Hu B, Zhou Y, Shang DY.
    Cardiovasc Ther; 2013 Apr 01; 31(2):108-14. PubMed ID: 23490237
    [Abstract] [Full Text] [Related]

  • 8. Effects of levosimendan/furosemide infusion on plasma brain natriuretic peptide, echocardiographic parameters and cardiac output in end-stage heart failure patients.
    Feola M, Lombardo E, Taglieri C, Vallauri P, Piccolo S, Valle R.
    Med Sci Monit; 2011 Feb 25; 17(3):PI7-13. PubMed ID: 21358614
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the clinical, hemodynamic and neurohormonal response to levosimendan administration in decompensated heart failure patients. One-month follow-up.
    Sargento L, Brito D, Matias JS, Madeira H.
    Rev Port Cardiol; 2007 Feb 25; 26(7-8):717-26. PubMed ID: 17939581
    [Abstract] [Full Text] [Related]

  • 10. Effects of levosimendan on right ventricular function in patients with advanced heart failure.
    Parissis JT, Paraskevaidis I, Bistola V, Farmakis D, Panou F, Kourea K, Nikolaou M, Filippatos G, Kremastinos D.
    Am J Cardiol; 2006 Dec 01; 98(11):1489-92. PubMed ID: 17126656
    [Abstract] [Full Text] [Related]

  • 11. Effects of levosimendan on markers of left ventricular diastolic function and neurohormonal activation in patients with advanced heart failure.
    Parissis JT, Panou F, Farmakis D, Adamopoulos S, Filippatos G, Paraskevaidis I, Venetsanou K, Lekakis J, Kremastinos DT.
    Am J Cardiol; 2005 Aug 01; 96(3):423-6. PubMed ID: 16054474
    [Abstract] [Full Text] [Related]

  • 12. Effects of serial levosimendan infusions on left ventricular performance and plasma biomarkers of myocardial injury and neurohormonal and immune activation in patients with advanced heart failure.
    Parissis JT, Adamopoulos S, Farmakis D, Filippatos G, Paraskevaidis I, Panou F, Iliodromitis E, Kremastinos DT.
    Heart; 2006 Dec 01; 92(12):1768-72. PubMed ID: 17105880
    [Abstract] [Full Text] [Related]

  • 13. Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function.
    Cioffi G, Tarantini L, Stefenelli C, Azzetti G, Marco R, Carlucci S, Furlanello F.
    J Card Fail; 2006 Oct 01; 12(8):608-15. PubMed ID: 17045179
    [Abstract] [Full Text] [Related]

  • 14. Hemodynamic effects of levosimendan in acute myocardial infarction complicated by cardiogenic shock and high systemic vascular resistance.
    Tsagalou EP, Kanakakis J, Anastasiou-Nana MI, Drakos SG, Ntalianis AS, Malliaras K, Lazaris N, Katsaros F, Nanas JN.
    Acute Card Care; 2009 Oct 01; 11(2):99-106. PubMed ID: 19353405
    [Abstract] [Full Text] [Related]

  • 15. Hospital costs for treatment of acute heart failure: economic analysis of the REVIVE II study.
    de Lissovoy G, Fraeman K, Teerlink JR, Mullahy J, Salon J, Sterz R, Durtschi A, Padley RJ.
    Eur J Health Econ; 2010 Apr 01; 11(2):185-93. PubMed ID: 19582491
    [Abstract] [Full Text] [Related]

  • 16. Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure.
    Cleland JG, Nikitin N, McGowan J.
    Expert Rev Cardiovasc Ther; 2004 Jan 01; 2(1):9-19. PubMed ID: 15038409
    [Abstract] [Full Text] [Related]

  • 17. Duration of the haemodynamic action of a 24-h infusion of levosimendan in patients with congestive heart failure.
    Lilleberg J, Laine M, Palkama T, Kivikko M, Pohjanjousi P, Kupari M.
    Eur J Heart Fail; 2007 Jan 01; 9(1):75-82. PubMed ID: 16829185
    [Abstract] [Full Text] [Related]

  • 18. Hemodynamic effects of levosimendan added to dobutamine in patients with decompensated advanced heart failure refractory to dobutamine alone.
    Nanas JN, Papazoglou PP, Terrovitis JV, Kanakakis J, Dalianis A, Tsolakis E, Tsagalou EP, Agrios N, Christodoulou K, Anastasiou-Nana MI.
    Am J Cardiol; 2004 Nov 15; 94(10):1329-32. PubMed ID: 15541261
    [Abstract] [Full Text] [Related]

  • 19. Treatment of experimental verapamil poisoning with levosimendan utilizing a rodent model of drug toxicity.
    Graudins A, Najafi J, Rur-SC MP.
    Clin Toxicol (Phila); 2008 Jan 15; 46(1):50-6. PubMed ID: 17926153
    [Abstract] [Full Text] [Related]

  • 20. Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair.
    Ponschab M, Hochmair N, Ghazwinian N, Mueller T, Plöchl W.
    Eur J Anaesthesiol; 2008 Aug 15; 25(8):627-33. PubMed ID: 18405408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.